Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration announced today it has cleared tests from Cepheid and Hologic that detect chlamydia and gonorrhea for use with extragenital specimens, specifically from the throat and rectum.

These assays are the first to be cleared for extragenital indications for chlamydia and gonorrhea testing, the agency said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.